The global market for Plant Derived Analgesics was valued at US$ 2157 million in the year 2024 and is projected to reach a revised size of US$ 3340 million by 2031, growing at a CAGR of 6.5% during the forecast period.

Plant Derived Analgesics Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Plant Derived Analgesics competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Plant Derived Analgesics refer to compounds or formulations extracted or isolated from natural plants that possess analgesic activity. These active ingredients relieve pain by modulating pain signal transmission in the central or peripheral nervous system. Compared with conventional synthetic analgesics, plant-derived alternatives are valued for their natural origin, higher safety profile, lower side effects, and better long-term tolerance. With the global resurgence of natural medicine R&D and the increasing demand for chronic pain management, this field is becoming a major focus for pharmaceutical companies. It covers multiple chemical classes such as alkaloids, flavonoids, terpenes, and glycosides, and is widely applied in treating osteoarthritis, neuropathic pain, cancer pain, and inflammatory pain. By integrating modern pharmaceutical technologies with advances in phytochemistry, plant-derived analgesics are steadily gaining prominence in the global pain management landscape.In 2024, global Plant Derived Analgesics production reached approximately 1078 m units, with an average global market price of around US$ 2 perunit.The average gross profit margin of this product is 55%.

With the growing global preference for “natural, safe, and sustainable” therapeutics, the market for plant-derived analgesics is experiencing a strong expansion. Regulatory bodies in multiple countries are accelerating the standardization and quality control of botanical drugs, integrating them into modern pharmaceutical frameworks. At the corporate level, major pharmaceutical and biotech firms are engaging in partnerships and acquisitions to advance standardized extraction, pharmacological studies, and market access. The rising prevalence of chronic pain and the aging population further provide a stable foundation for long-term market growth.Despite promising prospects, plant-derived analgesics face several obstacles, including inconsistency in quality, complex active compositions, and incomplete understanding of pharmacological mechanisms. Diverse regional regulations complicate international registration and commercialization. Moreover, raw material supply is vulnerable to environmental and climatic variations, posing challenges in pricing and sustainability. Meanwhile, synthetic drug manufacturers are increasingly developing biomimetic analogs of natural compounds, intensifying competition and pressuring innovation.In downstream markets, plant-derived analgesics are evolving from traditional herbal remedies to standardized pharmaceutical formulations and compound preparations. Hospitals, pharmacies, and online health channels are expanding their adoption, especially in chronic pain, geriatric care, and rehabilitation medicine. Consumers prefer clinically validated, traceable natural analgesics, while pharmaceutical companies are enhancing credibility through trials and regulatory approvals. The integration of botanical analgesics into functional foods and nutraceuticals is creating a new convergence between medicine, wellness, and consumer health sectors.The upstream segment primarily involves extracts from Papaveraceae, Zingiberaceae, Apocynaceae, and Lamiaceae plants. Advances in green extraction, biotransformation, and synthetic biology enable efficient purification and consistent quality control. Some raw materials have achieved traceable and eco-certified cultivation. Furthermore, global pharmaceutical firms are collaborating with agri-tech companies to establish sustainable sourcing systems, ensuring resource security and supporting the market’s long-term scalability.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Plant Derived Analgesics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plant Derived Analgesics.

The Plant Derived Analgesics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Plant Derived Analgesics market comprehensively. Regional market sizes, concerning products by Type, by Application, by Doses and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Plant Derived Analgesics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Doses and by regions.

Scope of Plant Derived Analgesics Market Report

Report Metric	Details
Report Name	Plant Derived Analgesics Market
Accounted market size in year	US$ 2157 million
Forecasted market size in 2031	US$ 3340 million
CAGR	6.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Morphine Codeine Salicin Cannabinoids (CBD) Other
Segment by Doses	Tablets Capsules Injectable Forms Other
Segment by End User	Chronic Pain Management Acute Pain Relief Post-Surgical Pain
Segment by Application	Hospitals Clinics Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Pfizer, Mallinckrodt Pharmaceuticals, Teva Pharmaceuticals, Johnson & Johnson, Purdue Pharma, Sun Pharmaceutical Industries, Hikma Pharmaceuticals, Indivior, Rhodes Pharmaceuticals, Mundipharma International, Xinan Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Plant Derived Analgesics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Plant Derived Analgesics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Plant Derived Analgesics Market growing?

Ans: The Plant Derived Analgesics Market witnessing a CAGR of 6.5% during the forecast period 2025-2031.

What is the Plant Derived Analgesics Market size in 2031?

Ans: The Plant Derived Analgesics Market size in 2031 will be US$ 3340 million.

Who are the main players in the Plant Derived Analgesics Market report?

Ans: The main players in the Plant Derived Analgesics Market are Pfizer, Mallinckrodt Pharmaceuticals, Teva Pharmaceuticals, Johnson & Johnson, Purdue Pharma, Sun Pharmaceutical Industries, Hikma Pharmaceuticals, Indivior, Rhodes Pharmaceuticals, Mundipharma International, Xinan Pharma

What are the Application segmentation covered in the Plant Derived Analgesics Market report?

Ans: The Applications covered in the Plant Derived Analgesics Market report are Hospitals, Clinics, Other

What are the Type segmentation covered in the Plant Derived Analgesics Market report?

Ans: The Types covered in the Plant Derived Analgesics Market report are Morphine, Codeine, Salicin, Cannabinoids (CBD), Other

What are the End User segmentation covered in the Plant Derived Analgesics Market report?

Ans: The End users covered in the Plant Derived Analgesics Market report are Chronic Pain Management, Acute Pain Relief, Post-Surgical Pain

1 Plant Derived Analgesics Market Overview

1.1 Product Definition

1.2 Plant Derived Analgesics by Type

1.2.1 Global Plant Derived Analgesics Market Value Comparison by Type (2024 VS 2031)

1.2.2 Morphine

1.2.3 Codeine

1.2.4 Salicin

1.2.5 Cannabinoids (CBD)

1.2.6 Other

1.3 Plant Derived Analgesics by Doses

1.3.1 Global Plant Derived Analgesics Market Value Comparison by Doses: 2024 VS 2031

1.3.2 Tablets

1.3.3 Capsules

1.3.4 Injectable Forms

1.3.5 Other

1.4 Plant Derived Analgesics by End User

1.4.1 Global Plant Derived Analgesics Market Value Comparison by End User: 2024 VS 2031

1.4.2 Chronic Pain Management

1.4.3 Acute Pain Relief

1.4.4 Post-Surgical Pain

1.5 Plant Derived Analgesics by Application

1.5.1 Global Plant Derived Analgesics Market Value by Application (2024 VS 2031)

1.5.2 Hospitals

1.5.3 Clinics

1.5.4 Other

1.6 Global Plant Derived Analgesics Market Size Estimates and Forecasts

1.6.1 Global Plant Derived Analgesics Revenue 2020-2031

1.6.2 Global Plant Derived Analgesics Sales 2020-2031

1.6.3 Global Plant Derived Analgesics Market Average Price (2020-2031)

1.7 Assumptions and Limitations

2 Plant Derived Analgesics Market Competition by Manufacturers

2.1 Global Plant Derived Analgesics Sales Market Share by Manufacturers (2020-2025)

2.2 Global Plant Derived Analgesics Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Plant Derived Analgesics Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Plant Derived Analgesics, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Plant Derived Analgesics, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Plant Derived Analgesics, Product Type & Application

2.7 Global Key Manufacturers of Plant Derived Analgesics, Date of Enter into This Industry

2.8 Global Plant Derived Analgesics Market Competitive Situation and Trends

2.8.1 Global Plant Derived Analgesics Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Plant Derived Analgesics Players Market Share by Revenue

2.8.3 Global Plant Derived Analgesics Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Plant Derived Analgesics Market Scenario by Region

3.1 Global Plant Derived Analgesics Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Plant Derived Analgesics Sales by Region: 2020-2031

3.2.1 Global Plant Derived Analgesics Sales by Region: 2020-2025

3.2.2 Global Plant Derived Analgesics Sales by Region: 2026-2031

3.3 Global Plant Derived Analgesics Revenue by Region: 2020-2031

3.3.1 Global Plant Derived Analgesics Revenue by Region: 2020-2025

3.3.2 Global Plant Derived Analgesics Revenue by Region: 2026-2031

3.4 North America Plant Derived Analgesics Market Facts & Figures by Country

3.4.1 North America Plant Derived Analgesics Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Plant Derived Analgesics Sales by Country (2020-2031)

3.4.3 North America Plant Derived Analgesics Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Plant Derived Analgesics Market Facts & Figures by Country

3.5.1 Europe Plant Derived Analgesics Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Plant Derived Analgesics Sales by Country (2020-2031)

3.5.3 Europe Plant Derived Analgesics Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Plant Derived Analgesics Market Facts & Figures by Region

3.6.1 Asia Pacific Plant Derived Analgesics Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Plant Derived Analgesics Sales by Region (2020-2031)

3.6.3 Asia Pacific Plant Derived Analgesics Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Plant Derived Analgesics Market Facts & Figures by Country

3.7.1 Latin America Plant Derived Analgesics Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Plant Derived Analgesics Sales by Country (2020-2031)

3.7.3 Latin America Plant Derived Analgesics Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Plant Derived Analgesics Market Facts & Figures by Country

3.8.1 Middle East and Africa Plant Derived Analgesics Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Plant Derived Analgesics Sales by Country (2020-2031)

3.8.3 Middle East and Africa Plant Derived Analgesics Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Plant Derived Analgesics Sales by Type (2020-2031)

4.1.1 Global Plant Derived Analgesics Sales by Type (2020-2025)

4.1.2 Global Plant Derived Analgesics Sales by Type (2026-2031)

4.1.3 Global Plant Derived Analgesics Sales Market Share by Type (2020-2031)

4.2 Global Plant Derived Analgesics Revenue by Type (2020-2031)

4.2.1 Global Plant Derived Analgesics Revenue by Type (2020-2025)

4.2.2 Global Plant Derived Analgesics Revenue by Type (2026-2031)

4.2.3 Global Plant Derived Analgesics Revenue Market Share by Type (2020-2031)

4.3 Global Plant Derived Analgesics Price by Type (2020-2031)

5 Segment by Application

5.1 Global Plant Derived Analgesics Sales by Application (2020-2031)

5.1.1 Global Plant Derived Analgesics Sales by Application (2020-2025)

5.1.2 Global Plant Derived Analgesics Sales by Application (2026-2031)

5.1.3 Global Plant Derived Analgesics Sales Market Share by Application (2020-2031)

5.2 Global Plant Derived Analgesics Revenue by Application (2020-2031)

5.2.1 Global Plant Derived Analgesics Revenue by Application (2020-2025)

5.2.2 Global Plant Derived Analgesics Revenue by Application (2026-2031)

5.2.3 Global Plant Derived Analgesics Revenue Market Share by Application (2020-2031)

5.3 Global Plant Derived Analgesics Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Pfizer

6.1.1 Pfizer Company Information

6.1.2 Pfizer Description and Business Overview

6.1.3 Pfizer Plant Derived Analgesics Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Pfizer Plant Derived Analgesics Product Portfolio

6.1.5 Pfizer Recent Developments/Updates

6.2 Mallinckrodt Pharmaceuticals

6.2.1 Mallinckrodt Pharmaceuticals Company Information

6.2.2 Mallinckrodt Pharmaceuticals Description and Business Overview

6.2.3 Mallinckrodt Pharmaceuticals Plant Derived Analgesics Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Mallinckrodt Pharmaceuticals Plant Derived Analgesics Product Portfolio

6.2.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates

6.3 Teva Pharmaceuticals

6.3.1 Teva Pharmaceuticals Company Information

6.3.2 Teva Pharmaceuticals Description and Business Overview

6.3.3 Teva Pharmaceuticals Plant Derived Analgesics Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Teva Pharmaceuticals Plant Derived Analgesics Product Portfolio

6.3.5 Teva Pharmaceuticals Recent Developments/Updates

6.4 Johnson & Johnson

6.4.1 Johnson & Johnson Company Information

6.4.2 Johnson & Johnson Description and Business Overview

6.4.3 Johnson & Johnson Plant Derived Analgesics Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Johnson & Johnson Plant Derived Analgesics Product Portfolio

6.4.5 Johnson & Johnson Recent Developments/Updates

6.5 Purdue Pharma

6.5.1 Purdue Pharma Company Information

6.5.2 Purdue Pharma Description and Business Overview

6.5.3 Purdue Pharma Plant Derived Analgesics Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Purdue Pharma Plant Derived Analgesics Product Portfolio

6.5.5 Purdue Pharma Recent Developments/Updates

6.6 Sun Pharmaceutical Industries

6.6.1 Sun Pharmaceutical Industries Company Information

6.6.2 Sun Pharmaceutical Industries Description and Business Overview

6.6.3 Sun Pharmaceutical Industries Plant Derived Analgesics Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Sun Pharmaceutical Industries Plant Derived Analgesics Product Portfolio

6.6.5 Sun Pharmaceutical Industries Recent Developments/Updates

6.7 Hikma Pharmaceuticals

6.7.1 Hikma Pharmaceuticals Company Information

6.7.2 Hikma Pharmaceuticals Description and Business Overview

6.7.3 Hikma Pharmaceuticals Plant Derived Analgesics Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Hikma Pharmaceuticals Plant Derived Analgesics Product Portfolio

6.7.5 Hikma Pharmaceuticals Recent Developments/Updates

6.8 Indivior

6.8.1 Indivior Company Information

6.8.2 Indivior Description and Business Overview

6.8.3 Indivior Plant Derived Analgesics Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Indivior Plant Derived Analgesics Product Portfolio

6.8.5 Indivior Recent Developments/Updates

6.9 Rhodes Pharmaceuticals

6.9.1 Rhodes Pharmaceuticals Company Information

6.9.2 Rhodes Pharmaceuticals Description and Business Overview

6.9.3 Rhodes Pharmaceuticals Plant Derived Analgesics Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Rhodes Pharmaceuticals Plant Derived Analgesics Product Portfolio

6.9.5 Rhodes Pharmaceuticals Recent Developments/Updates

6.10 Mundipharma International

6.10.1 Mundipharma International Company Information

6.10.2 Mundipharma International Description and Business Overview

6.10.3 Mundipharma International Plant Derived Analgesics Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Mundipharma International Plant Derived Analgesics Product Portfolio

6.10.5 Mundipharma International Recent Developments/Updates

6.11 Xinan Pharma

6.11.1 Xinan Pharma Company Information

6.11.2 Xinan Pharma Description and Business Overview

6.11.3 Xinan Pharma Plant Derived Analgesics Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Xinan Pharma Plant Derived Analgesics Product Portfolio

6.11.5 Xinan Pharma Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Plant Derived Analgesics Industry Chain Analysis

7.2 Plant Derived Analgesics Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Plant Derived Analgesics Production Mode & Process Analysis

7.4 Plant Derived Analgesics Sales and Marketing

7.4.1 Plant Derived Analgesics Sales Channels

7.4.2 Plant Derived Analgesics Distributors

7.5 Plant Derived Analgesics Customer Analysis

8 Plant Derived Analgesics Market Dynamics

8.1 Plant Derived Analgesics Industry Trends

8.2 Plant Derived Analgesics Market Drivers

8.3 Plant Derived Analgesics Market Challenges

8.4 Plant Derived Analgesics Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Mallinckrodt Pharmaceuticals

Teva Pharmaceuticals

Johnson & Johnson

Purdue Pharma

Sun Pharmaceutical Industries

Hikma Pharmaceuticals

Rhodes Pharmaceuticals

Mundipharma International

Xinan Pharma

List of Tables

Table 1. Global Plant Derived Analgesics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Plant Derived Analgesics Market Value by Doses, (US$ Million) & (2024 VS 2031)

Table 3. Global Plant Derived Analgesics Market Value by End User, (US$ Million) & (2024 VS 2031)

Table 4. Global Plant Derived Analgesics Market Value by Application (2024 VS 2031) & (US$ Million)

Table 5. Global Plant Derived Analgesics Market Competitive Situation by Manufacturers in 2024

Table 6. Global Plant Derived Analgesics Sales (K Units) of Key Manufacturers (2020-2025)

Table 7. Global Plant Derived Analgesics Sales Market Share by Manufacturers (2020-2025)

Table 8. Global Plant Derived Analgesics Revenue (US$ Million) by Manufacturers (2020-2025)

Table 9. Global Plant Derived Analgesics Revenue Share by Manufacturers (2020-2025)

Table 10. Global Market Plant Derived Analgesics Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 11. Global Key Players of Plant Derived Analgesics, Industry Ranking, 2022 VS 2023 VS 2024

Table 12. Global Key Manufacturers of Plant Derived Analgesics, Manufacturing Sites & Headquarters

Table 13. Global Key Manufacturers of Plant Derived Analgesics, Product Type & Application

Table 14. Global Key Manufacturers of Plant Derived Analgesics, Date of Enter into This Industry

Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 16. Global Plant Derived Analgesics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plant Derived Analgesics as of 2024)

Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 18. Global Plant Derived Analgesics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 19. Global Plant Derived Analgesics Sales by Region (2020-2025) & (K Units)

Table 20. Global Plant Derived Analgesics Sales Market Share by Region (2020-2025)

Table 21. Global Plant Derived Analgesics Sales by Region (2026-2031) & (K Units)

Table 22. Global Plant Derived Analgesics Sales Market Share by Region (2026-2031)

Table 23. Global Plant Derived Analgesics Revenue by Region (2020-2025) & (US$ Million)

Table 24. Global Plant Derived Analgesics Revenue Market Share by Region (2020-2025)

Table 25. Global Plant Derived Analgesics Revenue by Region (2026-2031) & (US$ Million)

Table 26. Global Plant Derived Analgesics Revenue Market Share by Region (2026-2031)

Table 27. North America Plant Derived Analgesics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 28. North America Plant Derived Analgesics Sales by Country (2020-2025) & (K Units)

Table 29. North America Plant Derived Analgesics Sales by Country (2026-2031) & (K Units)

Table 30. North America Plant Derived Analgesics Revenue by Country (2020-2025) & (US$ Million)

Table 31. North America Plant Derived Analgesics Revenue by Country (2026-2031) & (US$ Million)

Table 32. Europe Plant Derived Analgesics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 33. Europe Plant Derived Analgesics Sales by Country (2020-2025) & (K Units)

Table 34. Europe Plant Derived Analgesics Sales by Country (2026-2031) & (K Units)

Table 35. Europe Plant Derived Analgesics Revenue by Country (2020-2025) & (US$ Million)

Table 36. Europe Plant Derived Analgesics Revenue by Country (2026-2031) & (US$ Million)

Table 37. Asia Pacific Plant Derived Analgesics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 38. Asia Pacific Plant Derived Analgesics Sales by Region (2020-2025) & (K Units)

Table 39. Asia Pacific Plant Derived Analgesics Sales by Region (2026-2031) & (K Units)

Table 40. Asia Pacific Plant Derived Analgesics Revenue by Region (2020-2025) & (US$ Million)

Table 41. Asia Pacific Plant Derived Analgesics Revenue by Region (2026-2031) & (US$ Million)

Table 42. Latin America Plant Derived Analgesics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Latin America Plant Derived Analgesics Sales by Country (2020-2025) & (K Units)

Table 44. Latin America Plant Derived Analgesics Sales by Country (2026-2031) & (K Units)

Table 45. Latin America Plant Derived Analgesics Revenue by Country (2020-2025) & (US$ Million)

Table 46. Latin America Plant Derived Analgesics Revenue by Country (2026-2031) & (US$ Million)

Table 47. Middle East and Africa Plant Derived Analgesics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 48. Middle East and Africa Plant Derived Analgesics Sales by Country (2020-2025) & (K Units)

Table 49. Middle East and Africa Plant Derived Analgesics Sales by Country (2026-2031) & (K Units)

Table 50. Middle East and Africa Plant Derived Analgesics Revenue by Country (2020-2025) & (US$ Million)

Table 51. Middle East and Africa Plant Derived Analgesics Revenue by Country (2026-2031) & (US$ Million)

Table 52. Global Plant Derived Analgesics Sales (K Units) by Type (2020-2025)

Table 53. Global Plant Derived Analgesics Sales (K Units) by Type (2026-2031)

Table 54. Global Plant Derived Analgesics Sales Market Share by Type (2020-2025)

Table 55. Global Plant Derived Analgesics Sales Market Share by Type (2026-2031)

Table 56. Global Plant Derived Analgesics Revenue (US$ Million) by Type (2020-2025)

Table 57. Global Plant Derived Analgesics Revenue (US$ Million) by Type (2026-2031)

Table 58. Global Plant Derived Analgesics Revenue Market Share by Type (2020-2025)

Table 59. Global Plant Derived Analgesics Revenue Market Share by Type (2026-2031)

Table 60. Global Plant Derived Analgesics Price (US$/Unit) by Type (2020-2025)

Table 61. Global Plant Derived Analgesics Price (US$/Unit) by Type (2026-2031)

Table 62. Global Plant Derived Analgesics Sales (K Units) by Application (2020-2025)

Table 63. Global Plant Derived Analgesics Sales (K Units) by Application (2026-2031)

Table 64. Global Plant Derived Analgesics Sales Market Share by Application (2020-2025)

Table 65. Global Plant Derived Analgesics Sales Market Share by Application (2026-2031)

Table 66. Global Plant Derived Analgesics Revenue (US$ Million) by Application (2020-2025)

Table 67. Global Plant Derived Analgesics Revenue (US$ Million) by Application (2026-2031)

Table 68. Global Plant Derived Analgesics Revenue Market Share by Application (2020-2025)

Table 69. Global Plant Derived Analgesics Revenue Market Share by Application (2026-2031)

Table 70. Global Plant Derived Analgesics Price (US$/Unit) by Application (2020-2025)

Table 71. Global Plant Derived Analgesics Price (US$/Unit) by Application (2026-2031)

Table 72. Pfizer Company Information

Table 73. Pfizer Description and Business Overview

Table 74. Pfizer Plant Derived Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 75. Pfizer Plant Derived Analgesics Product

Table 76. Pfizer Recent Developments/Updates

Table 77. Mallinckrodt Pharmaceuticals Company Information

Table 78. Mallinckrodt Pharmaceuticals Description and Business Overview

Table 79. Mallinckrodt Pharmaceuticals Plant Derived Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 80. Mallinckrodt Pharmaceuticals Plant Derived Analgesics Product

Table 81. Mallinckrodt Pharmaceuticals Recent Developments/Updates

Table 82. Teva Pharmaceuticals Company Information

Table 83. Teva Pharmaceuticals Description and Business Overview

Table 84. Teva Pharmaceuticals Plant Derived Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 85. Teva Pharmaceuticals Plant Derived Analgesics Product

Table 86. Teva Pharmaceuticals Recent Developments/Updates

Table 87. Johnson & Johnson Company Information

Table 88. Johnson & Johnson Description and Business Overview

Table 89. Johnson & Johnson Plant Derived Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. Johnson & Johnson Plant Derived Analgesics Product

Table 91. Johnson & Johnson Recent Developments/Updates

Table 92. Purdue Pharma Company Information

Table 93. Purdue Pharma Description and Business Overview

Table 94. Purdue Pharma Plant Derived Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 95. Purdue Pharma Plant Derived Analgesics Product

Table 96. Purdue Pharma Recent Developments/Updates

Table 97. Sun Pharmaceutical Industries Company Information

Table 98. Sun Pharmaceutical Industries Description and Business Overview

Table 99. Sun Pharmaceutical Industries Plant Derived Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 100. Sun Pharmaceutical Industries Plant Derived Analgesics Product

Table 101. Sun Pharmaceutical Industries Recent Developments/Updates

Table 102. Hikma Pharmaceuticals Company Information

Table 103. Hikma Pharmaceuticals Description and Business Overview

Table 104. Hikma Pharmaceuticals Plant Derived Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 105. Hikma Pharmaceuticals Plant Derived Analgesics Product

Table 106. Hikma Pharmaceuticals Recent Developments/Updates

Table 107. Indivior Company Information

Table 108. Indivior Description and Business Overview

Table 109. Indivior Plant Derived Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 110. Indivior Plant Derived Analgesics Product

Table 111. Indivior Recent Developments/Updates

Table 112. Rhodes Pharmaceuticals Company Information

Table 113. Rhodes Pharmaceuticals Description and Business Overview

Table 114. Rhodes Pharmaceuticals Plant Derived Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 115. Rhodes Pharmaceuticals Plant Derived Analgesics Product

Table 116. Rhodes Pharmaceuticals Recent Developments/Updates

Table 117. Mundipharma International Company Information

Table 118. Mundipharma International Description and Business Overview

Table 119. Mundipharma International Plant Derived Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 120. Mundipharma International Plant Derived Analgesics Product

Table 121. Mundipharma International Recent Developments/Updates

Table 122. Xinan Pharma Company Information

Table 123. Xinan Pharma Description and Business Overview

Table 124. Xinan Pharma Plant Derived Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 125. Xinan Pharma Plant Derived Analgesics Product

Table 126. Xinan Pharma Recent Developments/Updates

Table 127. Key Raw Materials Lists

Table 128. Raw Materials Key Suppliers Lists

Table 129. Plant Derived Analgesics Distributors List

Table 130. Plant Derived Analgesics Customers List

Table 131. Plant Derived Analgesics Market Trends

Table 132. Plant Derived Analgesics Market Drivers

Table 133. Plant Derived Analgesics Market Challenges

Table 134. Plant Derived Analgesics Market Restraints

Table 135. Research Programs/Design for This Report

Table 136. Key Data Information from Secondary Sources

Table 137. Key Data Information from Primary Sources

Table 138. Authors List of This Report

List of Figures

Figure 1. Product Picture of Plant Derived Analgesics

Figure 2. Global Plant Derived Analgesics Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Plant Derived Analgesics Market Share by Type: 2024 & 2031

Figure 4. Morphine Product Picture

Figure 5. Codeine Product Picture

Figure 6. Salicin Product Picture

Figure 7. Cannabinoids (CBD) Product Picture

Figure 8. Other Product Picture

Figure 9. Global Plant Derived Analgesics Market Value by Doses, (US$ Million) & (2020-2031)

Figure 10. Global Plant Derived Analgesics Market Share by Doses: 2024 VS 2031

Figure 11. Tablets Product Picture

Figure 12. Capsules Product Picture

Figure 13. Injectable Forms Product Picture

Figure 14. Other Product Picture

Figure 15. Global Plant Derived Analgesics Market Value by End User, (US$ Million) & (2020-2031)

Figure 16. Global Plant Derived Analgesics Market Share by End User: 2024 VS 2031

Figure 17. Chronic Pain Management Product Picture

Figure 18. Acute Pain Relief Product Picture

Figure 19. Post-Surgical Pain Product Picture

Figure 20. Global Plant Derived Analgesics Market Value by Application (2020-2031) & (US$ Million)

Figure 21. Global Plant Derived Analgesics Market Share by Application: 2024 & 2031

Figure 22. Hospitals

Figure 23. Clinics

Figure 24. Other

Figure 25. Global Plant Derived Analgesics Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 26. Global Plant Derived Analgesics Market Size (2020-2031) & (US$ Million)

Figure 27. Global Plant Derived Analgesics Sales (2020-2031) & (K Units)

Figure 28. Global Plant Derived Analgesics Average Price (US$/Unit) & (2020-2031)

Figure 29. Plant Derived Analgesics Report Years Considered

Figure 30. Plant Derived Analgesics Sales Share by Manufacturers in 2024

Figure 31. Global Plant Derived Analgesics Revenue Share by Manufacturers in 2024

Figure 32. Global 5 and 10 Largest Plant Derived Analgesics Players: Market Share by Revenue in Plant Derived Analgesics in 2024

Figure 33. Plant Derived Analgesics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 34. Global Plant Derived Analgesics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 35. North America Plant Derived Analgesics Sales Market Share by Country (2020-2031)

Figure 36. North America Plant Derived Analgesics Revenue Market Share by Country (2020-2031)

Figure 37. United States Plant Derived Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Canada Plant Derived Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Europe Plant Derived Analgesics Sales Market Share by Country (2020-2031)

Figure 40. Europe Plant Derived Analgesics Revenue Market Share by Country (2020-2031)

Figure 41. Germany Plant Derived Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. France Plant Derived Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. U.K. Plant Derived Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Italy Plant Derived Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Russia Plant Derived Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Asia Pacific Plant Derived Analgesics Sales Market Share by Region (2020-2031)

Figure 47. Asia Pacific Plant Derived Analgesics Revenue Market Share by Region (2020-2031)

Figure 48. China Plant Derived Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Japan Plant Derived Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. South Korea Plant Derived Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. India Plant Derived Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Australia Plant Derived Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. China Taiwan Plant Derived Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Southeast Asia Plant Derived Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Latin America Plant Derived Analgesics Sales Market Share by Country (2020-2031)

Figure 56. Latin America Plant Derived Analgesics Revenue Market Share by Country (2020-2031)

Figure 57. Mexico Plant Derived Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 58. Brazil Plant Derived Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 59. Argentina Plant Derived Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 60. Colombia Plant Derived Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 61. Middle East and Africa Plant Derived Analgesics Sales Market Share by Country (2020-2031)

Figure 62. Middle East and Africa Plant Derived Analgesics Revenue Market Share by Country (2020-2031)

Figure 63. Turkey Plant Derived Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 64. Saudi Arabia Plant Derived Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 65. UAE Plant Derived Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 66. Global Sales Market Share of Plant Derived Analgesics by Type (2020-2031)

Figure 67. Global Revenue Market Share of Plant Derived Analgesics by Type (2020-2031)

Figure 68. Global Plant Derived Analgesics Price (US$/Unit) by Type (2020-2031)

Figure 69. Global Sales Market Share of Plant Derived Analgesics by Application (2020-2031)

Figure 70. Global Revenue Market Share of Plant Derived Analgesics by Application (2020-2031)

Figure 71. Global Plant Derived Analgesics Price (US$/Unit) by Application (2020-2031)

Figure 72. Plant Derived Analgesics Value Chain

Figure 73. Channels of Distribution (Direct Vs Distribution)

Figure 74. Bottom-up and Top-down Approaches for This Report

Figure 75. Data Triangulation

Figure 76. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions